Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Leases (2019 - 2025)

Standard Biotools (LAB) has disclosed Current Leases for 7 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Leases fell 16.48% to $5.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.1 million, a 16.48% decrease, with the full-year FY2024 number at $4.8 million, up 11.17% from a year prior.
  • Current Leases was $5.1 million for Q3 2025 at Standard Biotools, roughly flat from $5.1 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $6.3 million in Q1 2025 to a low of $3.0 million in Q2 2021.
  • A 5-year average of $4.5 million and a median of $4.3 million in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: surged 53.82% in 2024, then dropped 16.48% in 2025.
  • Standard Biotools' Current Leases stood at $3.1 million in 2021, then rose by 20.6% to $3.7 million in 2022, then rose by 17.41% to $4.3 million in 2023, then grew by 11.17% to $4.8 million in 2024, then increased by 6.39% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Current Leases are $5.1 million (Q3 2025), $5.1 million (Q2 2025), and $6.3 million (Q1 2025).